Follow The Filings

PRQR position history

The shares of Proqr Therapeutics (PRQR) that DAFNA Capital Management LLC reported in each quarter’s 13F.

Equity, SHS EURO

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 296,383 shares, $2.5M, 0.66% of portfolio
  2. 2021 Q4: 85,476 shares, $685K, 0.17% of portfolio, Reduce −71.2%
  3. 2022 Q1: not held, Exit
  4. 2022 Q2: not held
  5. 2022 Q3: 649,383 shares, $483K, 0.13% of portfolio, New
  6. 2022 Q4: not held, Exit
  7. 2023 Q1: 940,582 shares, $2M, 0.60% of portfolio, New
  8. 2023 Q2: 940,582 shares, $1.5M, 0.42% of portfolio
  9. 2023 Q3: 940,582 shares, $1.2M, 0.38% of portfolio
  10. 2023 Q4: 940,582 shares, $1.9M, 0.45% of portfolio
  11. 2024 Q1: 905,582 shares, $2.1M, 0.47% of portfolio, Reduce −3.7%
  12. 2024 Q2: 905,582 shares, $1.5M, 0.36% of portfolio
  13. 2024 Q3: 905,582 shares, $1.6M, 0.39% of portfolio
  14. 2024 Q4: 1,567,561 shares, $4.2M, 1.1% of portfolio, Add +73.1%
  15. 2025 Q1: 1,567,561 shares, $2.1M, 0.59% of portfolio
  16. 2025 Q2: 1,567,561 shares, $3.2M, 0.88% of portfolio
  17. 2025 Q3: 1,567,561 shares, $3.3M, 0.82% of portfolio
  18. 2025 Q4: 1,567,561 shares, $3.2M, 0.74% of portfolio
  19. 2026 Q1: 1,567,561 shares, $2.5M, 0.58% of portfolio
  20. 2026 Q2: 1,530,361 shares, $2.8M, 0.54% of portfolio, Reduce −2.4%
Holdings date Value % of holdings Shares Filing date All 13F holders